Todd Laffaye, BA

Todd Laffaye joined the Geriatric Psychiatry Research Program in mid-July 2022. As a former student visitor, Todd strengthened his interest in Alzheimer's disease research and care, which began as a senior in high school when Todd wrote a paper identifying aducanumab as the most promising treatment option for Alzheimer's disease (in 2018) before its groundbreaking FDA approval in 2021. As a member of the lab, Todd is excited to continue to learn more about aducanumab and the rapidly changing landscape of Alzheimer's care. 

CLICK HERE TO VOLUNTEER FOR RESEARCH

McLean Hospital • South Belknap • 115 Mill Street, Belmont, MA 02478 • ​(617) 855-2499
document.addEventListener(‘DOMContentLoaded’, function() { var element = document.getElementById(“weebly-footer-signup-container-v3”); element.parentNode.removeChild(element); }, false);